109748 ⎘
dsDNA viruses; Details; Baculoviridae; Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
AAV VECTORS PRODUCED BY INSECT CELLS COMPRISING REP52 AND REP78 CODING SEQUENCES WITH DIFFERENTIAL CODON BIASES
#2INFLUENZA VIRUS VACCINES AND USES THEREOF
#3BACULOVIRUS EXPRESSION SYSTEM
#4SPODOPTERA FRUGIPERDA PUPA OVARY CELL LINE WITH HIGH BACULOVIRUS PRODUCTION, AND CONSTRUCTION AND USE THEREOF
#5CHEMICALLY-DEFINED BACULOVIRUS EXPRESSION SYSTEM
#6INSECT CELLS AND METHODS FOR ENGINEERING THE SAME
#7RECOMBINANT THYROID-STIMULATING HORMONE RECEPTOR PROTEIN, PREPARATION METHOD AND APPLICATION THEREOF
#8HUMAN PAPILLOMAVIRUS TYPE 18 CHIMERIC PROTEIN AND USE THEREOF
#9METHODS FOR PRODUCING SINGLE INSECT CELL CLONES
#10METHODS FOR ANALYSIS OF VIRAL CAPSID PROTEIN COMPOSITION
#11VECTORS WITH MODIFIED INITIATION CODON FOR THE TRANSLATION OF AAV-REP78 USEFUL FOR PRODUCTION OF AAV
#12THERAPEUTIC VIRAL MICROPARTICLES FOR PROMOTING STENT BIOFUNCTIONALITY AND WOUND HEALING IN VERTEBRATE INDIVIDUALS
#13NUCLEIC ACID CONSTRUCT FOR INCREASING ADENO-ASSOCIATED VIRUS YIELD, AND CONSTRUCTION METHOD THEREFOR
#14MACHINE GUIDED DIRECTED EVOLUTION OF RAAV COMBINATORIAL CAPSID LIBRARIES
#15AUTOMATED PRODUCTION OF VIRAL VECTORS
#16Vaccine compositions having improved stability and immunogenicity
#17Methods for analysis of viral capsid protein composition
#18AAV VECTORS PRODUCED BY INSECT CELLS COMPRISING REP52 AND REP78 CODING SEQUENCES WITH DIFFERENTIAL CODON BIASES
#19Purification of virus like particles
#20NEW GENE THERAPY CONSTRUCTS
#21DUAL VECTOR SYSTEM FOR IMPROVED PRODUCTION OF PROTEINS IN ANIMAL CELLS
#22CHEMICALLY-DEFINED BACULOVIRUS EXPRESSION SYSTEM
#23Vaccine compositions
#24Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV
#25LIPID NANOPARTICLE FORMULATIONS OF NON-VIRAL, CAPSID-FREE DNA VECTORS
#26Optimised coding sequence and promoter
#27Methods for analysis of viral capsid protein composition
#28Porcine epidemic diarrhea virus S protein and subunit vaccine thereof as well as method for preparing subunit vaccine and application thereof
#29Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV
#30Methods for analysis of viral capsid protein composition
#31Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus
#32Vaccine compositions having improved stability and immunogenicity
#33Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
#34Piscine myocarditis virus-like particles and methods of use thereof
#35Mutated rep encoding sequences for use in AAV production
#36Functional influenza virus like particles (VLPs)
#37AAV vectors produced by insect cells comprising REP52 and REP78 coding sequences with differential codon biases
#38Purification of virus like particles
#39Biopesticide
#40Marker system, in particular for baculovirus-expressed subunit antigens
#41Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV
#42HPV particles and uses thereof
#43Method for producing virus like particles
#44Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals
#45INFLUENZA VIRUS VACCINES AND USES THEREOF
#46Highly efficient influenza matrix (M1) proteins
#47Functional influenza virus-like particles (VLPS)
#48Donor plasmid vectors
#49AAV production in insect cells, methods and compositions therefor
#50MEANS AND METHODS FOR PREPARING ENGINEERED PROTEINS BY GENETIC CODE EXPANSION IN INSECT CELLS
#51Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV
#52Piscine myocarditis virus-like particles and methods of use thereof
#53Porcine epidemic diarrhea virus vaccine
#54PCV2 immunogenic compositions and methods of producing such compositions
#55Method for preparing recombinant adeno-associated virus
#56Recombinant baculovirus and method for using the same for preparing recombinant adeno-associated virus vector
#57Mutated rep encoding sequences for use in AAV production
#58Vaccine compositions having improved stability and immunogenicity
#59Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
#60Functional influenza virus like particles (VLPs)
#61Optimised coding sequence and promoter
#62Circovirus sequences associated with piglet weight loss disease (PWD)
#63HPV particles and uses thereof
#64Methods for the diagnosis of cancer through detection of human endogenous retrovirus WL (HERV-WL) envelope expression
#65Highly efficient influenza matrix (M1) proteins
#66Functional influenza virus-like particles (VLPS)
#67Vaccine compositions having improved stability and immunogenicity
#68Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV
#69Prevention and treatment of sub-clinical PCVD
#70Vaccine compositions
#71Baculovirus display vectors and uses thereof
#72Diagnostic test for CSFV antibodies
#73Marker system, in particular for baculovirus-expressed subunit antigens
#74Puma protein expression vector and use thereof in gene therapy
#75Mutated rep encoding sequences for use in AAV production
#76Recombinant baculovirus expression vector and cell
#77Vectors
#78AAV vectors produced by insect cells comprising REP52 and REP78 coding sequences with differential codon biases
#79Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals
#80Functional influenza virus-like particles (VLPS)
#81Functional influenza virus like particles (VLPs)
#82Prevention and treatment of sub-clinical PCVD
#83Baculovirus system for expressing proteins forming virus-like particles
#84Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV
#85Highly efficient influenza matrix (M1) proteins
#86Porcine epidemic diarrhea virus vaccine
#87Optimised coding sequence and promoter
#88Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
#89PCV2 immunogenic compositions and methods of producing such compositions
#90Circovirus sequences associated with piglet weight loss disease (PWD)
#91Circovirus sequences associated with piglet weight loss disease (PWD)
#92Influenza virus vaccines and uses thereof
#93Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector
#94Method for preparing virus-like particle and recombinant baculovirus used therein
#95Baculovirus-based vaccines
#96Recombinant virus-like particles encoded by multi-gene vector
#97Recombinant baculovirus and use thereof
#98Method for producing recombinant prothrombin, vector DNA, and reagent kit
#99Functional influenza virus-like particles (VLPs)
#100Baculoviral vectors comprising repeated coding sequences with differential codon biases
#101Optimization of expression of parvoviral rep and cap proteins in insect cells
#102Purification of virus like particles
#103Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV
#104Functional influenza virus like particles (VLPs)
#105Prevention and treatment of sub-clinical PCVD
#106METHOD FOR PREPARING VIRUS-LIKE PARTICLE AND RECOMBINANT BACULOVIRUS USED THEREIN
#107Myostatin binding agents, nucleic acids encoding the same, and methods of treatment
#108Baculovirus-mediated transgene expression in both mammalian and insect cells
#109PCV2 immunogenic compositions and methods of producing such compositions
#110Universal vaccine against H5N1 lineages
#111Highly efficient influenza matrix (M1) proteins
#112METHODS FOR STABILIZING INFLUENZA ANTIGEN ENVELOPED VIRUS-BASED VIRUS-LIKE PARTICLE SOLUTIONS
#113HERPES SIMPLEX VIRUS COMBINED SUBUNIT VACCINES AND METHODS OF USE THEREOF
#114Optimised coding sequence and promoter
#115Mutated rep encoding sequences for use in AAV production
#116Recombinant baculovirus vaccine
#117Vaccine for chikungunya virus infection
#118INDUCIBLE BACULOVIRUS SYSTEM IN INSECT CELLS
#119Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector
#120Chimeral internal ribosomal entry site sequence and uses thereof
#121Composition and Method for Mediating an Immune Response
#122Functional influenza virus-like particles (VLPs)
#123HPV particles and uses thereof
#124Antitoxin and vaccine platform based on nodavirus VLPS
#125Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
#126Carrier peptide fragment and use thereof
#127ENHANCED PRODUCTION OF PAPILLOMAVIRUS-LIKE PARTICLES WITH A MODIFIED BACULOVIRUS EXPRESSION SYSTEM
#128FELINE INFECTIOUS PERITONITIS VACCINE
#129Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors
#130Norovirus capsid and rotavirus VP6 protein for use as combined vaccine
#131METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS
#132MYOSTATIN BINDING AGENTS
#133Chimeric antigens for eliciting an immune response
#134RECOMBINANT VIRUS-LIKE PARTICLES ENCODED BY MULTI-GENE VECTOR
#135Circovirus sequences associated with piglet weight loss disease (PWD)
#136Circovirus sequences associated with piglet weight loss disease (PWD)
#137Method for preparing recombinant antigen complex using rotavirus nanoparticle
#138Vectors
#139PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
#140METHODS FOR ISOLATING ENVELOPED VIRUS-BASED VLPS FREE OF INFECTIOUS AGENTS
#141IMMUNOGENIC AMPHIPATHIC PEPTIDE COMPOSITIONS
#142Method for purifying protein complexes
#143INSECT-DERIVED PROMOTERS FOR FOREIGN PROTEINS EXPRESSION IN INSECT CELLS
#144METHOD FOR PRODUCING RECOMBINANT VIRUS
#145Prevention and treatment of sub-clinical PCVD
#146Expression and assembly of human group C rotavirus-like particles and uses thereof
#147COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#148Optimization of expression of parvoviral rep and cap proteins in insect cells
#149Circovirus sequences associated with piglet weight loss disease (PWD)
#150Use of AAV replication machinery for improved protein production
#151ENHANCEMENT OF TRANSGENE EXPRESSION FROM VIRAL-BASED VACCINE VECTORS BY EXPRESSION OF SUPPRESSORS OF THE TYPE I INTERFERON RESPONSE
#152Efficient Insertion of DNA Into Embryonic Stem Cells
#153Claudin-4 binding peptides, compositions and methods of use
#154Virus-like particles as vaccines for paramyxovirus
#155Fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies
#156PCV-2 vaccine
#157Composition and Methods for Expressing Reporter Molecules in Mammalian Cells
#158Baculovirus expression vector and method therewith for generating immunogenicity in a host
#159Circovirus sequences associated with piglet weight loss disease (PWD)
#160CHIMERIC VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES
#161Immunomodulatory protein and useful embodiments thereof
#162Method of increasing muscle mass by administering a myostatin binding agent
#163Proteins derived from white spot syndrome virus and uses thereof
#164Baculoviruses with enhanced virion production and a method for the production of baculoviruses
#165Immunoprotective influenza antigen and its use in vaccination
#166Baculovirus-Based Vaccines
#167Baculoviral vectors comprising repeated coding sequences with differential codon biases
#168Dual expression vector system and screening methods
#169CHIMERIC NEWCASTLE DISEASE VIRUS VLPs
#170Recombinant baculovirus vaccine
#171CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#172Circovirus sequences associated with piglet weight loss disease (PWD)
#173CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#174CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#175CIRCOVIRUS SEQUENCE ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#176CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#177CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#178Circovirus sequences associated with piglet weight loss disease (PWD)
#179CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#180CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#181CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#182CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#183Avian influenza chimeric VLPS
#184CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#185CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#186Cell-proliferation inhibiting VPg proteins, fragments or analogs thereof and their applications
#187METHODS OF ENHANCING PROTEIN INCORPORATION INTO VIRUS LIKE PARTICLES
#188RECOMBINANT VIRAL VACCINE
#189Functional influenza virus like particles (VLPs)
#190VACCINE COMPOSITIONS AGAINST INFECTIOUS PATHOLOGIES FOR MAMMALS
#191Circovirus sequences associated with piglet weight loss disease (PWD)
#192VIROSOMES, METHODS OF PREPARATION, AND IMMUNOGENIC COMPOSITIONS
#193Method for sustained expression of an exogenous gene
#194Recombinant baculovirus vaccine
#195Vaccine comprising recombinant ct or lt toxin
#196Virus-like particles as vaccines for paramyxovirus
#197Method and constructs for delivering double stranded RNA to pest organisms
#198Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
#199Polynucleotides encoding myostatin binding agents
#200Binding agents which inhibit myostatin
#201ANCESTRAL DENGUE VIRUS ENVELOPE PROTEIN
#202Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV
#203Method of constructing recombinant proteoliposome for diagnostic use
#204Fusion Protein Comprising an Fc Receptor Binding Polypeptide and an Antigenic Polypeptide for Mediating an Immune Response
#205Engineered Baculoviruses and Their Use
#206Circovirus sequences associated with piglet weight loss disease (PWD)
#207Humanised Baculovirus
#208Circovirus sequences associated with piglet weight loss disease (PWD)
#209Chemokine binding activity of viral TNF receptors and related proteins
#210Circovirus sequences associated with piglet weight loss disease (PWD)
#211Canine respiratory coronavirus (CRCV) spike protein
#212Virus-like particles as vaccines for paramyxovirus
#213Proteins derived from white spot syndrome virus and uses thereof
#214Novel Neural Cell Specific Promoter And Baculovirus And Method For Gene Delivery
#215Avidin-Pseudotyped Viral Vectors and Their Use
#216Methods of overexpression and recovery of porcine circovirus type 2 ORF2
#217METHOD FOR GENE DELIVERY TO NEURONAL CELLS
#218PCV2 immunogenic compositions and methods of producing such compositions
#219PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
#220PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
#221PCV2 immunogenic compositions and methods of producing such compositions
#222PCV2 immunogenic compositions and methods of producing such compositions
#223Immunomodulatory protein and useful embodiments thereof
#224Prevention and treatment of sub-clinical PCVD
#225Humanised Baculovirus
#226COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#227COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#228Antitoxin and vaccine platform based on nodavirus VLPs
#229Nodavirus-Vlp Immunization Composition
#230Baculovirus-Based Gene Libraries
#231Pseudotyped Baculovirus and its Use
#232Baculovirus expression system
#233PCV-2 vaccine
#234Circovirus sequences associated with piglet weight loss disease (PWD)
#235COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#236COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#237COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#238COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#239Method of Delivering Nucleic Acid Molecules Into Embryonic Stem Cells Using Baculoviral Vectors
#240COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#241COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#242COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#243COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#244Virus-like particles for the induction of autoantibodies
#245Vaccine delivery compositions and methods of use
#246Anti-Cancer and Anti-Infectious Disease Compositions and Methods for Using Same
#247Protein isolation
#248Synthesis and Purification of West Nile Virus Virus-Like Particles
#249System for regulated and enhanced baculovirus mediated transient transgene expression in mammalian cells
#250New Expression Tools for Multiprotein Applications
#251Pseudotyped baculovirus to stimulate immunogenicity against avian influenza
#252COMPOSITION AND METHODS FOR EXPRESSING REPORTER MOLECULES IN MAMMALIAN CELLS
#253Rotavirus antigens
#254Circovirus sequences associated with piglet weight loss disease (PWD)
#255Canine respiratory coronavirus (CRCV) spike protein, polymerase and hemagglutinin/esterase
#256Method for Preparing Active Kinases Containing Ph Domains
#257Use of vaccines for the treatment/prevention of the transmission of pathogens
#258Functional influenza virus like particles (VLPs)
#259Virus-like particles as vaccines for paramyxovirus
#260Silkworm strains for enabling production of proteins using various baculovirus
#261Sars coronavirus s proteins and uses thereof
#262Circovirus sequences associated with piglet weight loss disease (PWD)
#263Circovirus sequences associated with piglet weight loss disease (PWD)
#264Circovirus sequences associated with piglet weight loss disease (PWD)
#265Circovirus sequences associated with piglet weight loss disease (PWD)
#266Circovirus sequences associated with piglet weight loss disease (PWD)
#267Circovirus sequences associated with piglet weight loss disease (PWD)
#268Circovirus sequences associated with piglet weight loss disease (PWD)
#269Circovirus sequences associated with piglet weight loss disease (PWD)
#270Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
#271Compositions and methods for the therapy and diagnosis of breast cancer
#272Preparing membrane receptors from extracellular baculoviruses
#273Avidin-pseudotyped viral vectors and their use
#274Use of HIV-1 gp120 and gp160 proteins modified in the V3 loop for the preparation of vaccine compositions and formulations containing the same
#275Circovirus sequences associated with piglet weight loss disease (PWD)
#276Circovirus sequences associated with piglet weight loss disease (PWD)
#277Internal ribosome entry site of the labial gene for protein expression
#278Virus-like particles for the induction of autoantibodies
#279Protective antigen of epstein barr virus
#280Modified baculovirus expression system for production of pseudotyped rAAV vector
#281Method for delivery of cosmetic by topical application
#282Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
#283Insect viruses and their uses in protecting plants
#284Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
#285Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
#286Virus-like particles, methods of preparation, and immunogenic compositions
#287Expressing transporters on viral envelopes
#288Circovirus sequences associated with piglet weight loss disease (PWD)
#289Vaccine for feline infectious peritonitis
#290Clonal cell lines derived from BTI-TN-5B1-4
#291Dual expression vector system and screening methods
#292Recombinant baculoviral vector containing protein transduction domain gene
#293Vectors and methods for gene transfer
#294Hepatitis c viral-like particle purification
#295Recombinant lentivirus encoding modified GP 120 signal sequences
#296Insect viruses and their uses in protecting plants
#297Circovirus sequences associated with piglet weight loss disease (PWD)
#298Peptide from the glycoprotein B from human herpesvirus 7 for use in a serological ELISA test
#299Baculovirus vector, method of producing thereof and method of gene transfer
#300Recombinant baculovirus and virus-like particle